BELLICUM PHARMACEUTICALS, INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$23.2M

456 transactions

Summary

BELLICUM PHARMACEUTICALS, INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.1MSales: $19.1M33 insiders

Date	Insider	Type	Value
2022-08-15	Fair Richard A.(President and CEO)	A	$576K
2022-08-15	Scripture Charity(Chief Development Officer)	A	$360K
2023-11-22	Joint reporting: BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC	X	$0
2023-11-22	Joint reporting: BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC	X	$0
2023-11-22	Joint reporting: BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC	X	$0
2023-11-22	Joint reporting: BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC	X	$0
2023-01-03	Klimovsky Judith V	M	$0
2023-01-03	Stonehouse Jon P	M	$0
2023-01-03	Huber Reid M	M	$0
2023-01-03	DAVIS STEPHEN	M	$0
2023-01-03	Daly James M	M	$0
2023-01-03	Huber Reid M	M	$0
2022-09-01	Stonehouse Jon P	M	$0
2022-09-01	Huber Reid M	M	$0
2022-09-01	Daly James M	M	$0
2022-09-01	DAVIS STEPHEN	M	$0
2022-09-01	Klimovsky Judith V	M	$0
2022-09-01	Stonehouse Jon P	M	$0
2022-06-15	Huber Reid M	A	$0
2022-06-15	Daly James M	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

BELLICUM PHARMACEUTICALS, INC — Contributions, Lobbying & Contracts | Poliscope